| Structure | Chemical Name | CAS | MF |
|
(1R,4bα,10aα)-Tetradecahydro-1β,4aβ,7-trimethyl-7α-[[(2,5-dihydro-5-oxofuran)-3-yl]methyl]-8β-hydroxyphenanthrene-1-carboxylic acid
|
|
|
|
Ciclesonide
|
126544-47-6
|
C32H44O7
|
|
|
Ralitrexed
|
|
|
|
Ralitoline
|
93738-40-0
|
|
|
|
rBAT protein
|
|
|
|
|
RaMage aMide linker resin (DL-forM) (200-400 Mesh)
|
|
|
|
|
Ramage-Synbeads
|
|
|
|
|
RBC AGAR
|
|
|
|
RAMAGE RESIN
|
|
C38H33NO3
|
|
|
rAmB220
|
|
|
|
|
RAMBACH EQUIVALENT AGAR
|
|
|
|
|
RAMBACH(R) AGAR
|
|
|
|
|
RAMALINALUSITANICA
|
|
|
|
|
Raman quartz cuvette
|
|
|
|
|
Raman quartz cuvette
|
|
|
|
|
Raman Spectra Of Polymers
|
|
|
|
|
Raman quartz cuvette
|
|
|
|
|
Raman quartz cuvette
|
|
|
|
|
Ramapatre
|
|
|
|
|
RamA protein, Klebsiella
|
|
|
|
|
RamA protein
|
|
|
|
|
RAMARIAFLAVO-BRUNNESCENS
|
|
|
|
|
RAMARIA
|
|
|
|
ramatroban
|
141281-95-0
|
C21H21FN2O4S
|
|
|
RBCA TXN SALTS
|
|
|
|
|
rAmCD4
|
|
|
|
|
rAmCD11b-FITC
|
|
|
|
|
rAmCD90Thy-1.2
|
|
|
|
|
rAmCD90Thy-1.1
|
|
|
|
|
rAmCD3
|
|
|
|
|
rAmCD90Thy-1
|
|
|
|
|
rAmCD80
|
|
|
|
|
rAmCD11a
|
|
|
|
|
RamB protein
|
|
|
|
RBAX
|
133433-82-6
|
C21H6Cl4I4O4
|
|
Ramciclane
|
96743-96-3
|
C21H33NO
|
|
(3R,3)-all-trans-Astaxanthin
|
71772-51-5
|
C40H52O4
|
|
|
RAMBUTAN
|
|
|
|
|
(2R)-2α-Allyl-3β-methylcyclohexanone
|
|
|
|
1-[(R)-2-(Allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
|
|
C14H14Cl2N2O
|
|
|
(4R)-4β-Allyl-4-methylnaphthalen-1(4H)-one
|
|
|
|
[R,(+)]-2-Allylvaleric acid
|
|
C8H14O2
|
|
|
(2R)-2α-Allyl-2,5-dihydro-3,6-dimethoxy-5β-isopropylpyrazine
|
|
|
|
[R,(+)]-4-Allylthio-2-aminobutyramide
|
|
C7H14N2OS
|
|
|
(R)-α-Allylcyclohexanemethanol
|
|
|
|
|
[R,(-)]-α-Allylbenzeneacetic acid sodium salt
|
|
|
|
|
(2R)-3-Allyl-2α,4β-dimethyl-3,4-dihydro-6-hydroxy-2H-naphth[2,1-e]-1,3-oxazine-7-carboxylic acid lactone
|
|
|
|
[R,(+)]-2-Allyl-1,4-butanediol
|
|
C7H14O2
|
|
|
(2R)-3-Allyl-2α,4β-bis(4-chlorophenyl)-3,4-dihydro-6-hydroxy-2H-naphth[2,1-e]-1,3-oxazine-7-carboxylic acid lactone
|
|
|
|
|
(1R,4α)-2-Allyl-1,7,7-trimethylbicyclo[2.2.1]heptane-2α-ol
|
|
|
|
[R,(+)]-Allylsuccinic acid
|
|
C7H10O4
|
|
(1R)-3-Allyl-6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
|
|
C19H20ClNO2
|
|
(R)-5-Allyl-2-oxabicyclo[3.3.0]oct-8-ene
|
911200-98-1
|
C10H14O
|
|
(R)-4-ALLYLOXAZOLIDIN-2-ONE
|
208041-36-5
|
C6H9NO2
|
|
(R)-[3-[2-(allyloxy)phenoxy]-2-hydroxypropyl]isopropylammonium chloride
|
29208-41-1
|
C15H24ClNO3
|
|
(R)-[[(allyloxy)carbonyl]amino](3-chloro-4-hydroxyphenyl)acetic acid
|
93841-52-2
|
C12H12ClNO5
|
|
(R)-[(allyloxy)carbonylamino](4-hydroxyphenyl)acetic acid
|
84792-41-6
|
C12H13NO5
|
|
(R)-3-(allyloxy)-2-(tert-butoxycarbonylamino)propanoic acid
|
660862-78-2
|
C11H19NO5
|
|
(R)-3-(allylamino)-2-(tert-butoxycarbonylamino)propanoic acid
|
|
C11H20N2O4
|
|
(R)-2-ALLYL-4-(1-AMINOETHYL)PHENOL
|
|
C11H15NO
|
|
(R)-Allylglycine (>98%, >99%ee)
|
|
C5H9NO2
|
|
|
RALMOUNT
|
|
|
|
|
RALMOUNT (FORMULATION RAYMOND A. LAMB)
|
|
|
|
[R-(all-Z)]-4-Hydroxy-N,N,N-triMethyl-10-oxo-7-[(1-oxooctadecyl)oxy]-3,5,9-trioxa-4-phosphahentriaconta-13,16,19,22,25,28-hexaen-1-aMiniuM Inner Salt 4-Oxide
|
99264-99-0
|
C48H84NO8P
|
|
|
R.B.C.Diluting Fluid (Grower's)
|
|
|
|
|
R.B.C.Diluting Fluid (Hayemis)
|
|
|
|
|
R B C Diluting Fluid (Hayem’S)
|
|
|
|
|
rAmCTLA-4
|
|
|
|
|
RalPantoneColor
|
|
|
|
Ramelteon Metabolite M-II-d3 (mixture of R and S at the hydroxy position)
|
1246812-22-5
|
C16H21NO3
|
|
|
Ramelteon,Insomnia
|
|
|
|
Ramelteon
|
196597-26-9
|
C16H21NO2
|
|
Ramelteon Metabolite M-II
|
896736-21-3
|
C16H21NO3
|
|
Ramelteon-d5
|
1134159-63-9
|
C16H21NO2
|
|
R-ALPENE -BORANE
|
|
C8H17BS2
|
|
(R)-ALPHA-PHENYL-1-PYRROLIDINEETHANAMINE
|
180305-85-5
|
C12H18N2
|
|
(R)-alpha-Methylaspartic acid-4-tert-butyl ester, 98% ee, 98%
|
1231709-25-3
|
C9H17NO4
|
|
Precursor of cefcapene diisopropylanmine salt
|
153012-37-4
|
C29H43N5O8S2
|
|
|
(R)-(+)-2-(alpha-(i-butyl)methanamine)-1H-benzimidazole, min. 98% (R)-i-Bu-BIMAH
|
|
C12H17N3
|
|
|
r3alpha-HSDH, 3alpha-Hydroxysteroid: NAD(P) oxidoreductase
|
|
|
|
(R)-3,alpha-Dimethyl-4-fluorobenzylamine hydrochloride
|
|
C9H13ClFN
|
|
(R)-alpha-Cyclopropyl-4-fluorobenzylamine hydrochloride
|
|
C10H13ClFN
|
|
(R)-alpha-Ethyl-4-fluorobenzylamine hydrochloride
|
1169576-95-7
|
C9H13ClFN
|
|
|
RbBP5 (human recombinant)
|
|
|
|
[1R-[1alpha(S*),3abeta,7aalpha]]-1-[2-(Acetyloxy)-1-methylethyl]octahydro-7a-methyl-4H-inden-4-one
|
141411-00-9
|
C15H24O3
|
|
[2R-(2alpha,6alpha,7alpha)]-7-(Benzoylamino)-3-methyl-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid diphenylmethyl ester
|
68314-21-6
|
C28H24N2O5
|
|
Sodium (R)-alpha-lipoate
|
176110-81-9
|
C8H15NaO2S2
|
|
(R)-alpha-Allylalanine hydrate, 98%, 98% ee
|
1266371-17-8
|
C6H13NO3
|
|
[1R-(1alpha,4abeta,10aalpha)]-1,2,3,4,4a,9,10,10a-octahydro-7-isopropyl-1,4a-dimethylphenanthren-1-methanol
|
3772-55-2
|
C20H30O
|
|
(25R)-5ALPHA-SPIROSTAN-2ALPHA,3BETA-DIOL
|
511-96-6
|
C27H44O4
|
|
(R)-ALPHA-(2-TRIFLUOROMETHYL-BENZYL)-PROLINE-HCL
|
1049727-87-8
|
C13H15ClF3NO2
|
|
(R)-ALPHA-(4-BIPHENYLMETHYL)-PROLINE-HCL
|
1049728-81-5
|
C18H20ClNO2
|
|
[1R-(1alpha,2beta,4beta,5beta,6alpha)]-5,7,7-trimethyl-oxatricyclo[4.1.1.02,4]octane
|
29391-40-0
|
C10H16O
|
|
(2R-(2alpha,4beta,5alpha))-5-Methyl-1-(tetrahydro-4-hydroxy-5-(1H-tetr azol-5-yl)-2-furanyl)-2,4(1H,3H)-pyrimidinedione
|
52995-50-3
|
C10H12N6O4
|
|
[1R-[1alpha(Z),2beta(S*),3alpha,5alpha]]-7-[2-(5-cyclohexyl-3-hydroxypent-1-ynyl)-3,5-dihydroxycyclopentyl]hept-5-enoic acid
|
59476-65-2
|
C23H36O5
|
|
(17R,21-alpha)-17,21-Dihydroxy-4-(2-propenyl)ajmalanium bromide
|
107870-71-3
|
C23H31N2O2.Br
|
|
(17R,21-alpha)-17,21-Dihydroxy-4-(2-hydroxy-3-pyrrolidinopropyl)ajmala nium
|
47719-73-3
|
C27H40N3O3
|
|
(R)(+)-ALPHA-PHENETHYLPHTHALIMIDE
|
|
C16H13NO2
|
|
3-(1'-(R)-ALPHA-METHYLBENZYL)-5(R)-HYDROXYMETHYL-OXAZOLIDIN-2-ONE
|
|
C12H15NO3
|
|
(R)-(-)-ALPHA-[(S)-2-(DIPHENYLPHOSPHINO)FERROCENYL]BENZYLAMINE
|
498580-48-6
|
C29H26FeNP10*
|